NO960965D0 - Genet Grb3-3 med varianter derav samt deres anvendelse - Google Patents

Genet Grb3-3 med varianter derav samt deres anvendelse

Info

Publication number: NO960965D0
Authority: NO; Norway
Prior art keywords: grb3; variants; gene; protein; sequences
Prior art date: 1993-09-15

Application number

NO960965A

Other languages

English (en)

Other versions

NO319144B1 (no

NO960965L (no

Inventor

Fabien Schweighoffer

Bruno Tocque

Original Assignee

Rhone Poulenc Rorer Sa

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1993-09-15

Filing date

1996-03-08

Publication date

1996-03-08

1996-03-08 Application filed by Rhone Poulenc Rorer Sa filed Critical Rhone Poulenc Rorer Sa

1996-03-08 Publication of NO960965D0 publication Critical patent/NO960965D0/no

1996-03-08 Publication of NO960965L publication Critical patent/NO960965L/no

2005-06-27 Publication of NO319144B1 publication Critical patent/NO319144B1/no

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/475—Growth factors; Growth regulators
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
- A61P31/18—Antivirals for RNA viruses for HIV
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P35/00—Antineoplastic agents
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07K—PEPTIDES
- C07K14/00—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof
- C07K14/435—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans
- C07K14/46—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates
- C07K14/47—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals
- C07K14/4701—Peptides having more than 20 amino acids; Gastrins; Somatostatins; Melanotropins; Derivatives thereof from animals; from humans from vertebrates from mammals not used
- C07K14/4702—Regulators; Modulating activity
- C07K14/4705—Regulators; Modulating activity stimulating, promoting or activating activity
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K38/00—Medicinal preparations containing peptides

Landscapes

Health & Medical Sciences (AREA)
Chemical & Material Sciences (AREA)
Life Sciences & Earth Sciences (AREA)
Organic Chemistry (AREA)
Medicinal Chemistry (AREA)
General Health & Medical Sciences (AREA)
Molecular Biology (AREA)
Zoology (AREA)
Toxicology (AREA)
Genetics & Genomics (AREA)
Biophysics (AREA)
Biochemistry (AREA)
Proteomics, Peptides & Aminoacids (AREA)
Gastroenterology & Hepatology (AREA)
Chemical Kinetics & Catalysis (AREA)
Veterinary Medicine (AREA)
Public Health (AREA)
General Chemical & Material Sciences (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Pharmacology & Pharmacy (AREA)
Animal Behavior & Ethology (AREA)
Virology (AREA)
Immunology (AREA)
Bioinformatics & Cheminformatics (AREA)
AIDS & HIV (AREA)
Tropical Medicine & Parasitology (AREA)
Engineering & Computer Science (AREA)
Communicable Diseases (AREA)
Oncology (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Micro-Organisms Or Cultivation Processes Thereof (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Enzymes And Modification Thereof (AREA)
Peptides Or Proteins (AREA)

NO19960965A 1993-09-15 1996-03-08 Nukleotidsekvens og dens anvendelse, vektor omfattende sekvensen samt farmasoytisk preparat omfattende vektoren. NO319144B1 (no)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
FR9310971A FR2710074B1 (fr)	1993-09-15	1993-09-15	Gène GRB3-3, ses variants et leurs utilisations.
PCT/FR1994/000542 WO1995007981A1 (fr)	1993-09-15	1994-05-09	Gene grb3-3, ses variants et leurs utilisations

Publications (3)

Publication Number	Publication Date
NO960965D0 true NO960965D0 (no)	1996-03-08
NO960965L NO960965L (no)	1996-03-08
NO319144B1 NO319144B1 (no)	2005-06-27

Family

ID=9450882

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
NO19960965A NO319144B1 (no)	1993-09-15	1996-03-08	Nukleotidsekvens og dens anvendelse, vektor omfattende sekvensen samt farmasoytisk preparat omfattende vektoren.

Country Status (27)

Country	Link
US (2)	US5831048A (no)
EP (1)	EP0719328B1 (no)
JP (1)	JP3794697B2 (no)
KR (1)	KR100330477B1 (no)
CN (1)	CN1098930C (no)
AT (1)	ATE196926T1 (no)
AU (1)	AU698819B2 (no)
BR (1)	BR9407693A (no)
CA (1)	CA2169938A1 (no)
CZ (1)	CZ288882B6 (no)
DE (1)	DE69426121T2 (no)
DK (1)	DK0719328T3 (no)
ES (1)	ES2152313T3 (no)
FI (1)	FI120499B (no)
FR (1)	FR2710074B1 (no)
GR (1)	GR3034600T3 (no)
HU (1)	HU221516B (no)
IL (2)	IL110942A (no)
NO (1)	NO319144B1 (no)
NZ (1)	NZ266162A (no)
PL (1)	PL178402B1 (no)
PT (1)	PT719328E (no)
RU (1)	RU2159815C2 (no)
SK (1)	SK281123B6 (no)
UA (1)	UA46715C2 (no)
WO (1)	WO1995007981A1 (no)
ZA (1)	ZA947059B (no)

Families Citing this family (14)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
FR2732348B1 (fr) *	1995-03-31	1997-04-30	Rhone Poulenc Rorer Sa	Systeme d'expression conditionnel
US6423824B1 (en)	1995-06-07	2002-07-23	Biogen, Inc.	CAIP-like gene family
US5837844A (en) *	1995-06-07	1998-11-17	Biogen, Inc.	CAIP-like gene family
US6171800B1 (en)	1995-06-07	2001-01-09	Biogen, Inc.	Method of making and binding CAIP polypeptides
US5855911A (en) *	1995-08-29	1999-01-05	Board Of Regents, The University Of Texas System	Liposomal phosphodiester, phosphorothioate, and P-ethoxy oligonucleotides
WO1997049808A1 (en) *	1996-06-27	1997-12-31	Biogen, Inc.	The caip-like gene family
US7309692B1 (en) *	1996-07-08	2007-12-18	Board Of Regents, The University Of Texas System	Inhibition of chronic myelogenous leukemic cell growth by liposomal-antisense oligodeoxy-nucleotides targeting to GRB2 or CRK1
US6977244B2 (en)	1996-10-04	2005-12-20	Board Of Regents, The University Of Texas Systems	Inhibition of Bcl-2 protein expression by liposomal antisense oligodeoxynucleotides
US7285288B1 (en)	1997-10-03	2007-10-23	Board Of Regents, The University Of Texas System	Inhibition of Bcl-2 protein expression by liposomal antisense oligodeoxynucleotides
US7704962B1 (en)	1997-10-03	2010-04-27	Board Of Regents, The University Of Texas System	Small oligonucleotides with anti-tumor activity
EP0998945A1 (en) *	1998-09-30	2000-05-10	Transgene S.A.	Use of magnesium (Mg2+) for the enhancement of gene delivery in gene therapy
NZ522045A (en)	2000-03-30	2007-05-31	Whitehead Biomedical Inst	RNA sequence-specific mediators of RNA interference
IL155991A0 (en) *	2000-12-01	2003-12-23	Max Planck Gesellschaft	Rna interference mediating small rna molecules
EP1460898A4 (en) *	2002-01-03	2006-05-24	Univ Texas	WT1 ANTISENSE OLIGOS FOR THE INHIBITION OF BREAST CANCER

Family Cites Families (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
CA2100860C (en) *	1991-01-18	2003-11-25	Joseph Schlessinger	A receptor tyrosine kinase target protein cdna cloning method and hgrb proteins
WO1994007913A1 (en) *	1992-09-25	1994-04-14	Warner-Lambert Company	Peptide antagonists of sh2 binding and therapeutic uses thereof

1993
- 1993-09-15 FR FR9310971A patent/FR2710074B1/fr not_active Expired - Fee Related
1994
- 1994-05-09 KR KR1019960701323A patent/KR100330477B1/ko not_active Expired - Fee Related
- 1994-05-09 US US08/612,857 patent/US5831048A/en not_active Ceased
- 1994-05-09 PL PL94313445A patent/PL178402B1/pl not_active IP Right Cessation
- 1994-05-09 US US09/641,640 patent/USRE37952E1/en not_active Expired - Fee Related
- 1994-05-09 JP JP50901595A patent/JP3794697B2/ja not_active Expired - Fee Related
- 1994-05-09 NZ NZ266162A patent/NZ266162A/en not_active IP Right Cessation
- 1994-05-09 UA UA96030994A patent/UA46715C2/uk unknown
- 1994-05-09 CA CA002169938A patent/CA2169938A1/fr not_active Abandoned
- 1994-05-09 CN CN94193814A patent/CN1098930C/zh not_active Expired - Fee Related
- 1994-05-09 BR BR9407693A patent/BR9407693A/pt not_active Application Discontinuation
- 1994-05-09 DK DK94915598T patent/DK0719328T3/da active
- 1994-05-09 ES ES94915598T patent/ES2152313T3/es not_active Expired - Lifetime
- 1994-05-09 PT PT94915598T patent/PT719328E/pt unknown
- 1994-05-09 EP EP94915598A patent/EP0719328B1/fr not_active Expired - Lifetime
- 1994-05-09 SK SK345-96A patent/SK281123B6/sk not_active IP Right Cessation
- 1994-05-09 CZ CZ1996758A patent/CZ288882B6/cs not_active IP Right Cessation
- 1994-05-09 HU HU9600668A patent/HU221516B/hu not_active IP Right Cessation
- 1994-05-09 RU RU96107888/13A patent/RU2159815C2/ru active
- 1994-05-09 DE DE69426121T patent/DE69426121T2/de not_active Expired - Fee Related
- 1994-05-09 AT AT94915598T patent/ATE196926T1/de not_active IP Right Cessation
- 1994-05-09 AU AU67247/94A patent/AU698819B2/en not_active Ceased
- 1994-05-09 WO PCT/FR1994/000542 patent/WO1995007981A1/fr not_active Ceased
- 1994-09-12 IL IL11094294A patent/IL110942A/en not_active IP Right Cessation
- 1994-09-12 IL IL126756A patent/IL126756A/en not_active IP Right Cessation
- 1994-09-13 ZA ZA947059A patent/ZA947059B/xx unknown
1996
- 1996-03-08 NO NO19960965A patent/NO319144B1/no not_active IP Right Cessation
- 1996-03-14 FI FI961202A patent/FI120499B/fi active IP Right Grant
2000
- 2000-10-12 GR GR20000401514T patent/GR3034600T3/el not_active IP Right Cessation

Also Published As

Publication number	Publication date
DK0719328T3 (da)	2000-11-13
IL126756A (en)	2006-06-11
CZ288882B6 (cs)	2001-09-12
SK281123B6 (sk)	2000-12-11
KR100330477B1 (ko)	2002-12-02
US5831048A (en)	1998-11-03
BR9407693A (pt)	1997-02-04
UA46715C2 (uk)	2002-06-17
ES2152313T3 (es)	2001-02-01
CZ75896A3 (en)	1996-06-12
DE69426121T2 (de)	2001-05-31
EP0719328A1 (fr)	1996-07-03
JP3794697B2 (ja)	2006-07-05
IL110942A0 (en)	1994-11-28
FI961202L (fi)	1996-03-14
FI961202A0 (fi)	1996-03-14
PT719328E (pt)	2001-02-28
ZA947059B (en)	1995-05-18
AU6724794A (en)	1995-04-03
PL313445A1 (en)	1996-07-08
NO319144B1 (no)	2005-06-27
ATE196926T1 (de)	2000-10-15
DE69426121D1 (de)	2000-11-16
HU9600668D0 (en)	1996-05-28
JPH09502357A (ja)	1997-03-11
CN1133064A (zh)	1996-10-09
FR2710074B1 (fr)	1995-12-08
SK34596A3 (en)	1996-07-03
EP0719328B1 (fr)	2000-10-11
RU2159815C2 (ru)	2000-11-27
FI120499B (fi)	2009-11-13
PL178402B1 (pl)	2000-04-28
FR2710074A1 (fr)	1995-03-24
HU221516B (hu)	2002-11-28
GR3034600T3 (en)	2001-01-31
HUT74273A (en)	1996-11-28
WO1995007981A1 (fr)	1995-03-23
NZ266162A (en)	1997-11-24
CN1098930C (zh)	2003-01-15
NO960965L (no)	1996-03-08
USRE37952E1 (en)	2002-12-31
IL110942A (en)	2001-12-23
AU698819B2 (en)	1998-11-05
CA2169938A1 (fr)	1995-03-23

Publication	Publication Date	Title
NO960965L (no)	1996-03-08	Genet Grb3-3 med varianter derav samt deres anvendelse
ATE154029T1 (de)	1997-06-15	7-deazapurin modifizierte oligonukleotide
PT1548032E (pt)	2009-08-13	Péptidos kdr e vacinas que os contêm
DK265685D0 (da)	1985-06-13	Thrombininhibitorer samt deres fremstilling og anvendelse
ES2173867T3 (es)	2002-11-01	Uso de nucleotidos externos a la muestra en clonacion genetica.
EP1005540A4 (en)	2003-04-02	IKK-BETA PROTEINS, NUCLEIC ACIDS AND METHODS
ATE323770T1 (de)	2006-05-15	Polypeptide mit lysophospholipaseaktivität und nukleinesäuren die sie kodieren
ATE384787T1 (de)	2008-02-15	Tripeptidyl-aminopeptidase
EP0953641A3 (en)	2002-03-13	Polynucleotide molecules encoding neospora proteins
DE69321720D1 (de)	1998-11-26	Für den interleukin-9-rezeptor kodierende nukleinsäuresequenzen bzw. dafür komplementäre nuleinsäuresequenzen
ATE215123T1 (de)	2002-04-15	Or-1, ein wais-rezeptor der nuklearen rezeptoren familie
HUP0400915A2 (hu)	2004-09-28	Növényi reprodukciós proteinek
DK1032683T3 (da)	2005-06-06	Polypeptider med 5-aminolevulinsyre-syntase-aktivitet og nukleinsyrer, der koder for disse
GB9720038D0 (en)	1997-11-19	Control
WO2001014519A3 (en)	2001-08-30	Methods and compositions for regulating developmental identity
CA2419038A1 (en)	2003-02-11	Nucleic acid and protein increasing expression levels under salt stress
NO996424D0 (no)	1999-12-23	Komplementaer cDNA-sekvens, vektor inneholdende denne, protein samt anvendelse av proteinet
EP1221486A3 (en)	2002-10-23	Polynucleotide molecules encoding neospora proteins
AP2961A (en)	2014-09-30	An isolated nucleotide sequence and transgenic organism containing said sequence.
CO5400145A1 (es)	2004-05-31	Proteina asociada con enfermedad

Legal Events

Date	Code	Title	Description
2010-12-27	MM1K	Lapsed by not paying the annual fees